Our Supporters

Merck

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life—from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.


Merus Logo

Merus N.V., founded in 2003, is a clinical-stage biotechnology company headquartered in Utrecht, the Netherlands, dedicated to advancing cancer treatment through antibody-based therapies.

Merus focuses primarily on oncology, developing therapies that address a wide range of solid tumours and haematologic cancers. Its research targets pathways involved in tumour growth, immune evasion, and cell signalling, with the goal of delivering more effective and durable treatment options. By combining deep scientific expertise with cutting-edge antibody engineering, Merus is working to redefine how complex cancers are treated and to expand the potential of multispecific antibody therapeutics in precision medicine.